AnaptysBio Reports Imsidolimab ACORN Phase 2 Clinical Trial Data in Moderate-to-Severe Acne
Source:
Nasdaq GlobeNewswire
/
14 Mar 2022 16:20:00 America/New_York
N/A
Share on,